Covered when ONE of the following indications is met (each line describes a distinct qualifying indication):
Female partner age ≥ 35 after attempting conception for ≥ 6 months.age ≥ 35 and ≥ 6 months attempted conception
Evidence of diminished ovarian reserve defined by low AMH, persistent bilateral antral follicle count (AFC) < 5, or early follicular FSH ≥ 10.0, consistent over 2–3 determinations.AFC < 5; FSH ≥ 10.0; consistency on 2–3 tests
Male factor infertility: ejaculated sperm unsuitable for IUI (poor count, motility, or morphology), <5% normal morphology by strict Kruger criteria, <5 million total motile sperm, or sperm obtainable only via urine, epididymal aspiration/testicular biopsy, or electroejaculation.<5% normal morphology OR <5 million total motile sperm
Tubal disease: idiopathic or iatrogenic irreparable bilateral tubal occlusion, bilateral hydrosalpinx, prior bilateral salpingectomy, or severely abnormal tubes on laparoscopy.
Severe pelvic adhesions diagnosed by laparoscopy.
Prior laparotomy where laparoscopic evaluation is contraindicated, or severe pelvic adhesions diagnosed by laparoscopy.
Polycystic Ovary Syndrome (PCOS) when ovulation induction with oral agents fails to produce follicular growth, or >3 ovulation induction cycles fail to result in conception, or when oral agents routinely produce >2 dominant follicles.>3 failed cycles or >2 dominant follicles with oral agents
Recurrent pregnancy loss: 2–3 clinical pregnancy losses confirmed by ultrasound (age-dependent) with negative evaluation for underlying cause.2–3 clinical pregnancy losses (age-dependent)
Chunk 8 specifies differing counts by maternal age.
Balanced chromosome translocation in either partner when preimplantation genetic testing for structural rearrangements (PGT‑SR) would be performed.
High risk for genetic disease in offspring: a dominant disorder in either partner or the same recessive disorder in both partners where preimplantation genetic testing for monogenic/single gene disorders (PGT‑M) would be used.
Fertility preservation: embryo creation or oocyte cryopreservation prior to cancer treatment or other therapies toxic to ovaries/oocytes.
Requirement for a gestational carrier due to prior hysterectomy, pregnancy medically contraindicated, or severe uterine anomaly.
Unexplained infertility after failed ovulation induction/IUI: no successful conception after 3 properly managed ovulation induction cycles, with or without intrauterine insemination, managed by an OBGYN or reproductive endocrinologist.No conception after 3 properly managed cycles